Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy

Introduction. Stevens-Johnson syndrome (SJS) is an uncommon and potentially serious mucocutaneous disease. The most important step in the management of SJS is early recognition and immediate withdrawal of the causative agent. We present a patient with SJS associated with dimercaptopropane-1-sulfonat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical toxicology (Philadelphia, Pa.) Pa.), 2008-06, Vol.46 (5), p.479-481
Hauptverfasser:	Van der Linde, A.A.A., Pillen, S., Gerrits, G.P.J.M., Bouwes Bavinck, J.N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidotes - therapeutic use Biological and medical sciences Bullous diseases of the skin Chelating Agents - therapeutic use Chemical and industrial products toxicology. Toxic occupational diseases Child Dermatology Environmental Exposure - adverse effects Humans Male Medical sciences Mercury Compounds - poisoning Mercury Poisoning Metals and various inorganic compounds Stevens-Johnson Syndrome - chemically induced Toxicology Unithiol - therapeutic use Volatilization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Introduction. Stevens-Johnson syndrome (SJS) is an uncommon and potentially serious mucocutaneous disease. The most important step in the management of SJS is early recognition and immediate withdrawal of the causative agent. We present a patient with SJS associated with dimercaptopropane-1-sulfonate (DMPS) therapy. Case Report. An asymptomatic 11-year old boy who had been exposed chronically to mercury vapour had a 24-hour urine mercury concentration of 37 microgram L (reference value
ISSN:	0731-3810 1556-3650 1097-9875 1556-9519
DOI:	10.1080/15563650701779687